These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 9075264

  • 1. Cloning, expression and characterization of a human dopamine D4.2 receptor (CHO K1 cells) and various D4.2/D2L chimeras (COS-7 cells).
    Shih YH, Chung FZ, Pugsley TA.
    Prog Neuropsychopharmacol Biol Psychiatry; 1997 Jan; 21(1):153-67. PubMed ID: 9075264
    [Abstract] [Full Text] [Related]

  • 2. Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907.
    Pugsley TA, Davis MD, Akunne HC, MacKenzie RG, Shih YH, Damsma G, Wikstrom H, Whetzel SZ, Georgic LM, Cooke LW.
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1355-66. PubMed ID: 8531103
    [Abstract] [Full Text] [Related]

  • 3. Cloning, expression, functional coupling and pharmacological characterization of the rat dopamine D4 receptor.
    Gazi L, Schoeffter P, Nunn C, Croskery K, Hoyer D, Feuerbach D.
    Naunyn Schmiedebergs Arch Pharmacol; 2000 May; 361(5):555-64. PubMed ID: 10832611
    [Abstract] [Full Text] [Related]

  • 4. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
    Newman-Tancredi A, Audinot V, Chaput C, Verrièle L, Millan MJ.
    J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
    [Abstract] [Full Text] [Related]

  • 5. Zinc modulates antagonist interactions with D2-like dopamine receptors through distinct molecular mechanisms.
    Schetz JA, Chu A, Sibley DR.
    J Pharmacol Exp Ther; 1999 May; 289(2):956-64. PubMed ID: 10215675
    [Abstract] [Full Text] [Related]

  • 6. Receptor density as a factor governing the efficacy of the dopamine D4 receptor ligands, L-745,870 and U-101958 at human recombinant D4.4 receptors expressed in CHO cells.
    Gazi L, Bobirnac I, Danzeisen M, Schüpbach E, Langenegger D, Sommer B, Hoyer D, Tricklebank M, Schoeffter P.
    Br J Pharmacol; 1999 Oct; 128(3):613-20. PubMed ID: 10516640
    [Abstract] [Full Text] [Related]

  • 7. Potent activation of dopamine D3/D2 heterodimers by the antiparkinsonian agents, S32504, pramipexole and ropinirole.
    Maggio R, Scarselli M, Novi F, Millan MJ, Corsini GU.
    J Neurochem; 2003 Nov; 87(3):631-41. PubMed ID: 14535946
    [Abstract] [Full Text] [Related]

  • 8. Pharmacology of a human dopamine D4 receptor expressed in HEK293 cells.
    Lawson CF, Mortimore RA, Schlachter SK, Smith MW.
    Methods Find Exp Clin Pharmacol; 1994 Jun; 16(5):303-7. PubMed ID: 7934308
    [Abstract] [Full Text] [Related]

  • 9. Characterization of binding of [3H]PD 128907, a selective dopamine D3 receptor agonist ligand, to CHO-K1 cells.
    Akunne HC, Towers P, Ellis GJ, Dijkstra D, Wikström H, Heffner TG, Wise LD, Pugsley TA.
    Life Sci; 1995 Jun; 57(15):1401-10. PubMed ID: 7674830
    [Abstract] [Full Text] [Related]

  • 10. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants.
    Asghari V, Sanyal S, Buchwaldt S, Paterson A, Jovanovic V, Van Tol HH.
    J Neurochem; 1995 Sep; 65(3):1157-65. PubMed ID: 7643093
    [Abstract] [Full Text] [Related]

  • 11. Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors.
    Mierau J, Schneider FJ, Ensinger HA, Chio CL, Lajiness ME, Huff RM.
    Eur J Pharmacol; 1995 Jun 23; 290(1):29-36. PubMed ID: 7664822
    [Abstract] [Full Text] [Related]

  • 12. The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor.
    Gazi L, Bobirnac I, Danzeisen M, Schüpbach E, Bruinvels AT, Geisse S, Sommer B, Hoyer D, Tricklebank M, Schoeffter P.
    Br J Pharmacol; 1998 Jul 23; 124(5):889-96. PubMed ID: 9692773
    [Abstract] [Full Text] [Related]

  • 13. WAY-100635 is a potent dopamine D4 receptor agonist.
    Chemel BR, Roth BL, Armbruster B, Watts VJ, Nichols DE.
    Psychopharmacology (Berl); 2006 Oct 23; 188(2):244-51. PubMed ID: 16915381
    [Abstract] [Full Text] [Related]

  • 14. Modulation of agonist binding to human dopamine receptor subtypes by L-prolyl-L-leucyl-glycinamide and a peptidomimetic analog.
    Verma V, Mann A, Costain W, Pontoriero G, Castellano JM, Skoblenick K, Gupta SK, Pristupa Z, Niznik HB, Johnson RL, Nair VD, Mishra RK.
    J Pharmacol Exp Ther; 2005 Dec 23; 315(3):1228-36. PubMed ID: 16126839
    [Abstract] [Full Text] [Related]

  • 15. Neuropharmacological assessment of potential dopamine D4 receptor-selective radioligands.
    Kula NS, Tarazi FI, Baldessarini RJ, Xu L, Bakthavachalam V, Pounds S, True CD.
    Eur J Pharmacol; 1999 Feb 12; 367(1):139-42. PubMed ID: 10082277
    [Abstract] [Full Text] [Related]

  • 16. D2S, D2L, D3, and D4 dopamine receptors couple to a voltage-dependent potassium current in N18TG2 x mesencephalon hybrid cell (MES-23.5) via distinct G proteins.
    Liu LX, Burgess LH, Gonzalez AM, Sibley DR, Chiodo LA.
    Synapse; 1999 Feb 12; 31(2):108-18. PubMed ID: 10024007
    [Abstract] [Full Text] [Related]

  • 17. Design, synthesis, and evaluation of chromen-2-ones as potent and selective human dopamine D4 antagonists.
    Kesten SR, Heffner TG, Johnson SJ, Pugsley TA, Wright JL, Wise LD.
    J Med Chem; 1999 Sep 09; 42(18):3718-25. PubMed ID: 10479303
    [Abstract] [Full Text] [Related]

  • 18. D4 dopamine receptor-mediated signaling events determined in transfected Chinese hamster ovary cells.
    Chio CL, Drong RF, Riley DT, Gill GS, Slightom JL, Huff RM.
    J Biol Chem; 1994 Apr 22; 269(16):11813-9. PubMed ID: 7512953
    [Abstract] [Full Text] [Related]

  • 19. In vitro pharmacological profile of YM-43611, a novel D2-like receptor antagonist with high affinity and selectivity for dopamine D3 and D4 receptors.
    Hidaka K, Tada S, Matsumoto M, Ohmori J, Tasaki Y, Nomura T, Usuda S, Yamaguchi T.
    Br J Pharmacol; 1996 Apr 22; 117(8):1625-32. PubMed ID: 8732269
    [Abstract] [Full Text] [Related]

  • 20. Comparison of in vitro binding properties of a series of dopamine antagonists and agonists for cloned human dopamine D2S and D2L receptors and for D2 receptors in rat striatal and mesolimbic tissues, using [125I] 2'-iodospiperone.
    Leysen JE, Gommeren W, Mertens J, Luyten WH, Pauwels PJ, Ewert M, Seeburg P.
    Psychopharmacology (Berl); 1993 Apr 22; 110(1-2):27-36. PubMed ID: 7870895
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.